+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Hemophilia Market and Competitive Landscape - 2020

  • ID: 5023457
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Hemophilia Market and Competitive Landscape - 2020, provides comprehensive insights into the Hemophilia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Hemophilia market size and drug sales. It also provides insights into Hemophilia epidemiology and late stage pipeline.

This research covers the following: Hemophilia treatment options, Hemophilia late stage clinical trials pipeline, Hemophilia prevalence by countries, Hemophilia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Hemophilia pipeline: Find out drugs in clinical trials for the treatment of Hemophilia by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Hemophilia epidemiology: Find out the number of patients diagnosed (prevalence) with Hemophilia by countries
  • Hemophilia drugs: Identify key drugs marketed and prescribed for Hemophilia in the US, including trade name, molecule name, and company
  • Hemophilia drugs sales: Find out the sales value for Hemophilia drugs by countries
  • Hemophilia market valuations: Find out the market size for Hemophilia drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Hemophilia drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Hemophilia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Hemophilia market
  • Develop in-depth knowledge of competition and markets
  • Analyze Hemophilia drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Hemophilia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Hemophilia Treatment Options

2. Hemophilia Pipeline Insights
2.1. Hemophilia Phase 3 Clinical Trials
2.2. Hemophilia Phase 2 Clinical Trials
2.3. Hemophilia Phase 1 Clinical Trials

3. Hemophilia Epidemiology Analysis by Countries

4. Germany Hemophilia Market Insights
4.1. Marketed Drugs for Hemophilia in Germany
4.2. Germany Hemophilia Market Size & Forecast
4.3. Germany Hemophilia Drugs Sales Forecast
4.4. Germany Hemophilia Market Share Analysis

5. France Hemophilia Market Insights
5.1. Marketed Drugs for Hemophilia in France
5.2. France Hemophilia Market Size & Forecast
5.3. France Hemophilia Product Sales Forecast
5.4. France Hemophilia Market Share Analysis

6. Italy Hemophilia Market Insights
6.1. Marketed Drugs for Hemophilia in Italy
6.2. Italy Hemophilia Market Size & Forecast
6.3. Italy Hemophilia Product Sales Forecast
6.4. Italy Hemophilia Market Share Analysis

7. Spain Hemophilia Market Insights
7.1. Marketed Drugs for Hemophilia in Spain
7.2. Spain Hemophilia Market Size & Forecast
7.3. Spain Hemophilia Product Sales Forecast
7.4. Spain Hemophilia Market Share Analysis

8. UK Hemophilia Market Insights
8.1. Marketed Drugs for Hemophilia in UK
8.2. UK Hemophilia Market Size & Forecast
8.3. UK Hemophilia Product Sales Forecast
8.4. UK Hemophilia Market Share Analysis

9. Europe Hemophilia Market Insights
9.1. Europe Hemophilia Market Size & Forecast
9.2. Europe Hemophilia Product Sales Forecast
9.3. Europe Hemophilia Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Hemophilia Phase 3 Clinical Trials, Global, 2020
Table 2: Hemophilia Phase 2 Clinical Trials, Global, 2020
Table 3: Hemophilia Phase 1 Clinical Trials, Global, 2020
Table 4: Hemophilia Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Hemophilia in Germany, 2019
Table 6: Germany Hemophilia Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Hemophilia Product Sales ($mn), 2016 - 2024
Table 8: Germany Hemophilia Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Hemophilia in France, 2019
Table 10: France Hemophilia Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Hemophilia Product Sales ($mn), 2016 - 2024
Table 12: France Hemophilia Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Hemophilia in Italy, 2019
Table 14: Italy Hemophilia Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Hemophilia Product Sales ($mn), 2016 - 2024
Table 16: Italy Hemophilia Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Hemophilia in Spain, 2019
Table 18: Spain Hemophilia Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Hemophilia Product Sales ($mn), 2016 - 2024
Table 20: Spain Hemophilia Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Hemophilia in UK, 2019
Table 22: UK Hemophilia Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Hemophilia Product Sales ($mn), 2016 - 2024
Table 24: UK Hemophilia Market Events and Trends, 2016 - 2024
Table 25: Europe Hemophilia Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Hemophilia Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Hemophilia Pipeline by Phase (%), Global, 2020
Figure 2: Hemophilia Prevalence by Countries, 2016 - 2024
Figure 3: Germany Hemophilia Market Size ($mn), 2016 - 2024
Figure 4: Germany Hemophilia Product Sales ($mn), 2016 - 2024
Figure 5: Germany Hemophilia Market Share by Drugs (%), 2019
Figure 6: Germany Hemophilia Market - Future Market Share (%), 2024
Figure 7: France Hemophilia Market Size ($mn), 2016 - 2024
Figure 8: France Hemophilia Product Sales ($mn), 2016 - 2024
Figure 9: France Hemophilia Market Share by Drugs (%), 2019
Figure 10: France Hemophilia Market - Future Market Share (%), 2024
Figure 11: Italy Hemophilia Market Size ($mn), 2016 - 2024
Figure 12: Italy Hemophilia Product Sales ($mn), 2016 - 2024
Figure 13: Italy Hemophilia Market Share by Drugs (%), 2019
Figure 14: Italy Hemophilia Market - Future Market Share (%), 2024
Figure 15: Spain Hemophilia Market Size ($mn), 2016 - 2024
Figure 16: Spain Hemophilia Product Sales ($mn), 2016 - 2024
Figure 17: Spain Hemophilia Market Share by Drugs (%), 2019
Figure 18: Spain Hemophilia Market - Future Market Share (%), 2024
Figure 19: UK Hemophilia Market Size ($mn), 2016 - 2024
Figure 20: UK Hemophilia Product Sales ($mn), 2016 - 2024
Figure 21: UK Hemophilia Market Share by Drugs (%), 2019
Figure 22: UK Hemophilia Market - Future Market Share (%), 2024
Figure 23: Europe Hemophilia Market Size ($mn), 2016 - 2024
Figure 24: Europe Hemophilia Product Sales ($mn), 2016 - 2024
Figure 25: Europe Hemophilia Market Share by Drugs (%), 2019
Figure 26: Europe Hemophilia Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll